gp46. Restriction endonuclease maps of PNG-1 proviral DNA differed from that ofa prototype strain ofHTLV-I (MT-2), but, as verified by polymerase chain reaction, PNG-1 was definitely HTLV-I, not HTLV-II. Nucleotide sequencing and further molecular genetic studies of this variant may provide insights into the origin and evolution of HTLV-I.
Moderately to extraordinarily high prevalences of antibodies against human T-lymphotropic virus type I (HTLV-I) have been found in several remote population groups in Melanesia (Papua New Guinea, West New Guinea, Solomon Islands, Vanuatu, and New Caledonia) by using screening tests such as enzyme-linked immunosorbent assay and gelatin particle agglutination (1) (2) (3) (4) (5) (6) (7) (8) (9) . However, the failure to confirm HTLV-I seropositivity in many Melanesian sera by Western blot analysis (2, 7, 8) , the inability of such sera to neutralize a prototype strain of HTLV-I (2, 10) , and the absence of diseases caused by HTLV-I have called into question the veracity of these high prevalences, leading some investigators to dismiss the claims of HTLV-I hyperendemicity in Melanesia as artifactual and clinically unimportant (4, 10) . In support of the existence of HTLV-I in Melanesia, we have recently identified a case of HTLV-I myeloneuropathy in a lifelong resident of the Solomon Islands (11, 12) and have detected HTLV-I genomic sequences by polymerase chain reaction (PCR) in lymphocytes from this patient (13) . More Hagahai, a small group of hunter-horticulturalists living in the fringe highlands of Papua New Guinea (14) , and have isolated a variant of HTLV-I from a healthy, asymptomatic carrier (15) . We now report on the further characterization of this variant. (19, 20 (26, 27) , pol (SK110, bases 4757-4778; SKill, bases 4919-4942) (28) , env (bases 5684-5707 and 6128-6151) (26) , and tax/rex (bases 7358-7374 and 7496-7516) (29) This resulted, after =3 weeks, in the establishment of a long-term T-cell line, designated PNG-1, which expressed CD2 (99%), CD3 (99%), CD7 (97%), CD8 (93%), and HLA-DR (95%) surface markers. Expression of CD4 was detected at a low level (14%), as was expression of CD33 (14%), CD19 (1%), and CD20 (3%). PNG-l cells required exogenous interleukin 2 for optimal growth and periodically exhibited widespread cell death. As determined by HLA typing, the PNG-l cell line (All, B56, B62, C4, DR2, DQ1) did not have antigens in common with either the umbilical cord blood cells (A2, B8, B57) or MOLT-3 cells (Al, A25, B18).
MATERIALS AND METHODS
Rare virus particles resembling HTLV-I were observed only after PNG-l cells were incubated with 5-bromo-2'-deoxyuridine (Fig. 1) . The virus particles, measuring 100-120 nm in diameter, exhibited an electron-dense central nucleoid surrounded by an outer membrane. Multivesicular bodies, occasionally seen in cell lines infected with HTLV-I, were also evident (Fig. 1) . Budding particles were not seen.
All attempts to isolate HTLV-I from six other Western blot-positive Hagahai (including the mother and brother of the young man from whom PNG-1 was derived) and from 17 Western immunoblot-indeterminate individuals were unsuccessful, but supernatant fluids from two other cultures contained low levels of reverse transcriptase activity and rare HTLV-I-like particles were observed by thin-section electron microscopy. However, no long-term cell lines could be established.
Antigenic Characterization. By double-label immunofluorescence, the same cells were stained by using sera from patients with HTLV-I myeloneuropathy and sera from rabbits experimentally infected with HTLV-I (Fig. 2) . Unlike MT-2 cells, which exhibited robust fluorescence with monoclonal and polyclonal antibodies to native and synthetic peptides of p19 and p24, PNG-1 cells exhibited no staining (data not shown). However, like MT-2 cells, PNG-1 cells were immunoreactive with polyclonal antibodies directed against a synthetic peptide spanning the extreme C terminus of the major envelope glycoprotein gp46.
Immunofluorescence data were corroborated by Western blot analysis: lysates of PNG-1 cells exhibited virus-specific bands at 15, 19, 46, 53, and 61/68 kDa when sera from patients with HTLV-I myeloneuropathy and from HTLV-Iinfected rabbits and polyclonal antibodies against gp46 were used. By contrast, monoclonal antibodies directed against HTLV-I gag-encoded proteins p19 and p24 failed to label these proteins in PNG-1 cell lysates (Fig. 3) . No reactivity was found by immunofluorescence or Western immunoblot with sera from HTLV-I-seronegative humans and rabbits.
Gene Amplification and Restriction Maps. HTLV-I genomic sequences were detected by PCR in DNA extracted from PNG-1 cells, using oligonucleotide primers specific for gag, pol, env, and tax/rex sequences of ATK-1. HTLV-I env sequences were evident only after nested PCR (Fig. 4) . Taq I digestion ofthe 159-base-pair (bp) tax/rex amplified product from PNG-1 DNA resulted in a 138-bp rather than an 85-bp fragment, indicating that PNG-1 was HTLV-I, not HTLV-II (Fig. 5) . No HTLV-I sequences were found by PCR in MOLT-3 DNA.
Restriction enzyme maps of PNG-1 proviral DNA were similar to but distinct from that of a prototype strain of HTLV-I (MT-2). A single band >9 kilobases (kb) was found after EcoRI digestion, indicating that PNG-1 DNA, like MT-2 DNA, did not contain an EcoRI cleavage site. Analysis ofPst I digests of PNG-1 proviral DNA indicated two cleavage sites, instead of the five or six typically found in prototype strains ofHTLV-I. Thus, the three moderate-sized fragments of approximately 2.4, 1.6, and 1.3 kb generated by Pst I digestion of prototype strains of HTLV-I were not evident in PNG-1 DNA (Fig. 6) . Instead, fragments of 5.0 and 4.4 kb were found. When digested with Pst I, DNA isolated from fresh, uncultured mononuclear cells of the Hagahai man from whom the PNG-1 cell line was derived, and from cells of his seropositive mother and brother, showed no hybridization with a full-length HTLV-I probe, probably due to the low copy number of the proviral genome. 
DISCUSSION
Our data, indicating that a variant of HTLV-I is present among a small, recently contacted group in Papua New Guinea, dispel all remaining doubts that HTLV-I exists in Melanesia. Moreover, the remoteness of the Hagahai, and their isolation from Japanese and Africans, are consistent with the long endemicity of HTLV-I in Melanesia (8, 12, 14) .
This variant, the first HTLV-I isolate from Papua New Guinea, differed in some notable respects from HTLV-I strains isolated from patients with adult T cell leukemia/ lymphoma and tropical spastic paraparesis/HTLV-Iassociated myelopathy and from asymptomatic carriers in the Caribbean basin, Colombia, and southwestern Japan. First, as judged by Southern blot analysis of Pst I digests, PNG-1 proviral DNA was atypical, indicating a variant provirus. Second, the failure of monoclonal and polyclonal antibodies directed against p19 and p24 to label PNG-1 cells by immunofluorescence or to label viral gag-encoded proteins by Western immunoblot indicates possible epitopic differences and/or low level expression of these proteins. Finally, the scant production of mature virus particles even after induction with the nucleoside analogue 5-bromo-2'-deoxyuridine suggests possible differences in regulatory control of replication or maturation.
Infection ofumbilical cord mononuclear cells with HTLV-I usually results in cell transformation and abundant virus production (24, 31, 32) . However, some HTLV-I-trans- formed T-cell lines, established by cocultivating cord blood lymphocytes with virus-infected cells, are nonproducers and exhibit restricted expression of viral structural proteins (33) . Similarly, the PNG-1 cell line, which was established after cocultivation with umbilical cord blood lymphocytes and later with MOLT-3, produced few mature virus particles and exhibited markedly reduced expression of gag-encoded proteins. However, the HLA phenotype of PNG-1 cells was distinct from that of the umbilical cord blood cells and MOLT-3 cells used in cocultivation and was consistent with HLA antigens found among the Hagahai (17) . Thus, the PNG-1 cell line originated from the asymptomatic Hagahai individual.
HTLV-I-infected T cells in vivo (34) and persistently infected T-cell lines (31, 35) are typically CD4+. By contrast, the PNG-1 cell line was predominantly CD8+. As has been suggested for isolates of human immunodeficiency virus (HIV), virus-infected CD4+-activated T cells may be recognized and killed by CD8+ cells in vitro, leading to the isolation of variants (36) . The expansion of CD4+ and CD8+ T cells in culture, with subsequent killing of virus-infected cells by CD8+ cells, may also explain the spontaneous cell death periodically observed during the maintanence ofPNG-1 cells, as well as the difficulty encountered in isolating HTLV-I from the other Western immunoblot-positive Hagahai.
The Hagahai, like several other Melanesian populations, exhibit high frequencies of indeterminate HTLV-I Western immunoblots, characterized by strong reactivity to multiple gag-encoded proteins without antibodies to env gene products (2, 8, 12, 14) . Although our attempts to isolate HTLV-I from such individuals in this study were unsuccessful, HTLV-I genomic sequences have recently been detected by PCR in some Melanesians with indeterminate HTLV-I Western immunoblots (unpublished observations). Renewed virus isolation attempts are necessary to determine whether these individuals are infected with HTLV-I variants, in light of the recent isolation of a HIV variant from a healthy individual with an indeterminate HIV Western blot from Gabon, Africa (37) . The Gabon HIV isolate did not possess particularly divergent env-encoded proteins, but sera from HIV Western blot-indeterminate individuals failed to immunoprecipitate these proteins. In Gabon, then, an abnormal host immune response may be responsible at least for a portion of the Medical Sciences: Yanagihara et al.
atypical Western blot patterns. By analogy, some Melanesians with indeterminate HTLV-I Western immunoblots may truly be infected but, for unknown reasons, fail to respond immunologically to HTLV-I env proteins. Alternatively, HTLV-I variants from Papua New Guinea, such as PNG-1, may have sufficiently divergent env glycoproteins, such that accurate serodiagnosis cannot be afforded by using commercially available Western immunoblots that utilize prototype strains of HTLV-I.
It is unclear whether infection with this HTLV-I variant is restricted to the Hagahai or is more widespread in Melanesia. More prototypical strains of HTLV-I, like those isolated recently from Solomon Islanders (13), may also circulate among the Hagahai. Even if PNG-1 is found not to be the major HTLV-I strain in Papua New Guinea, its isolation is no less significant. The abundant expression of env gene products, as demonstrated by immunofluorescence and Western blot analysis, and the near absence of mature virions, as judged by electron microscopy, may make PNG-1 a suitable strain for use in diagnostic tests and vaccine development. Moreover, nucleotide sequencing ofPNG-1 proviral DNA, as well as studies of the biology and virology of this variant, will help to elucidate how this virus is maintained and disseminated in isolated population groups and provide insights into the origin and evolution of HTLV-I.
